The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

Multiple Sclerosis Journal

Volumn 18, Issue 7, 2012, Pages 974-982

  Lechner Scott, Jeannette ^a,b   Spencer, B ^a   De Malmanche, T ^a   Attia, J ^a,b   Fitzgerald, M ^b   Trojano, M ^c   Grand'Maison, F ^d   Gomez, J Antonio C ^e   Izquierdo, G ^f   Duquette, P ^g   Girard, M ^h   Grammond, P ^h   Oreja Guevara, C ⁱ   Hupperts, R ^j   Bergamaschi, R ^k   Boz, C ^l   Giuliani, G ^m   Van Pesch, V ⁿ   Iuliano, G ^o   Fiol, M ^p   Cristiano, E ^q   Verheul, F ^r   Saladino, M Laura ^s   Slee, M ^t   Barnett, M ^u   Deri, N ^v   Flechter, S ^w   Vella, N ^x   Shaw, C ^y   Herbert, J ^z   Moore, F ^aa   Petkovska Boskova, T ^ab   Jokubaitis, V ^ac   Butzkueven, H ^ac,ad,ae   more..

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF BARI   (Italy)

^d Neuro Rive Sud   (Canada)

^e HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^f HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^g NOTRE DAME HOSPITAL   (Canada)

^h Hotel Dieu de Levis Hospital   (Canada)

ⁱ HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^j Sittard Geleen Heerlen   (Netherlands)

^k C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^l KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^m Ospedale di Macerata   (Italy)

ⁿ CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^o Ospedali Riuniti di Salerno   (Italy)

^p FLENI   (Argentina)

^q HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^r Groene Hart Ziekenhuis   (Netherlands)

^s INEBA   (Argentina)

^t FLINDERS UNIVERSITY   (Australia)

^u UNIVERSITY OF SYDNEY   (Australia)

^v HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^w ASSAF HAROFEH MEDICAL CENTER   (Israel)

^x MATER DEI HOSPITAL   (Malta)

^y GEELONG HOSPITAL   (Australia)

^z NYU HOSPITAL FOR JOINT DISEASES   (United States)

^aa MCGILL UNIVERSITY   (Canada)

^ab Clinic of Neurology Clinical Center   (Macedonia)

^ac ROYAL MELBOURNE HOSPITAL   (Australia)

^ad UNIVERSITY OF MELBOURNE   (Australia)

^ae MONASH UNIVERSITY   (Australia)

more..

Author keywords

data base; latitude; multiple sclerosis; oligoclonal bands; prognosis; progression 2

Indexed keywords

OLIGOCLONAL BAND;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISABILITY; DISEASE REGISTRY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LATITUDE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT;

EID: 84863196420     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511431729     Document Type: Article

References (33)

1. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
2. Montalban X, Sastre-Garriga J, Filippi M et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler 2009; 15: 1459-1465.
3. Kostulas VK, Link H and Lefvert AK. Oligoclonal IgG bands in cerebrospinal fluid: principles for demonstration and interpretation based on findings in 1114 neurological patients. Arch Neurol 1987; 44: 1041-1044.
4. McLean BN, Luxton RW and Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the log IgG-Index. Brain 1990; 113: 1269-1289. (Pubitemid 20385912)
5. Siritho S and Freedman MS. The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 2009; 279: 21-25.
6. Wu JS, Zhang MN, Carroll WM et al. Characterisation of the spectrum of demyelinating disease in a Western Australian cohort. J Neurol Neurosurg Psych 2008; 79: 1022-1026.
7. Gama PD, Machado Ldos R, Livramento JA et al. Study of oligoclonal bands restricted to the cerebrospinal fluid in multiple sclerosis patients in the city of São Paulo. Arg Neuropsiquiatr 2009; 67: 1017-1022.
8. Idiman E, Ozakbas S, Dogan Y and Kosehasanogullari G. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenic backgrounds. J Neuroimmunol 2009; 212: 121-124.
9. Fukazawa T, Kikuchi S, Sasaki H, et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenic backgrounds. J Neurol Sci 1998; 158: 209-214. (Pubitemid 28342086)
10. Siritho S and Prayoonwiwat N. A retrospective study of multiple sclerosis in Siriraj Hospital, Bangkok, Thailand. Can J Neurol Sci 2007; 34: 99-104. (Pubitemid 46423351)
11. Siritho S, Nakashima I, Takahashi T, Fujihara K and Prayoonwiwat N. AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology 2011; 77: 827-834.
12. Tintore M, Rovira A, Rio J et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70: 1079-1083. (Pubitemid 351464763)
13. Sa MJ, Sequeira L and Rio ME. Oligoclonal IgG bands in the cerebrospinal fluid of Portuguese patients with multiple sclerosis: negative results indicate benign disease. Arq Neuro-Psiquiatria 2005; 63(2B): 375-379. (Pubitemid 40942361)
14. Koch M, Heersema D, Mostert J et al. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis. Eur J Neurol 2007; 14: 797-800. (Pubitemid 47012193)
15. Imrell K, Landtblom A-M and Hillert J. Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct. Neurology 2006; 67: 1062-1064. (Pubitemid 44454606)
16. Zeman AZJ, Kidd D, McLean BN et al. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psych 1996; 60: 27-30. (Pubitemid 26013190)
17. Butzkueven H, Chapman J, Cristiano E et al. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler 2006; 12: 769-774. (Pubitemid 46111769)
18. Lundkvist M, Greiner E, Hillert J et al. Multiple sclerosis patients lacking OCB in the CSF are less likely to develop neutralizing antibodies against interferon beta. Mult Scler 2010; 16: 796-800.
19. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005; 62: 865-870. (Pubitemid 40973448)
20. Kikuchi S, Fukazawa T, Niino M et al. HLA-related subpopulation of MS in Japanese with and without oligoclonal bands. Human leukocyte antigen. Neurology 2003; 60: 647-51. (Pubitemid 36246084)
21. Wu JS, Qui W, Castley A et al. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB 1 genotype in a Western Australian multiple sclerosis cohort. J Neurol Sci 2010; 288: 63-67.
22. Romero-Pinel L, Martínez-Yélamos S, Bau L, et al. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 2011; DOI: 10.1111/j.1468-1331.2011. 03379.
23. Balnyte R, Rastenyte D,Lauckaite K, Vaitkus A, Vitkauskiene A and Skrodeniene E. Association of HLA DRB1*1501 and oligoclonal bands with clinical features and disability in multiple sclerosis. Mult Scler 2011; 17(Suppl. 10): S113.
24. Simpson S Jr, Blizzard L, Otahal P, Van der Mei I and Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011; 82: 1132-1141.
25. Van der Walt A, Stankovich J, Bahlo M, et al. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler 2010; [Epub ahead of print].
26. Patrucco L, Larriba J, Redal MA, Rojas JI, Argibay PF and Cristiano E. HLA-DRB1 and multiple sclerosis in Argentina. Eur J Neurol 2009; 16: 427-429.
27. Joseph FG, Hirst CL, Pickersgill TP, et al. CSF oligoclonal band isoforms prognosis in multiple sclerosis: a case control study of 100 patients. H Neurol Neurosurg Psych 2009; 80: 292-296.
28. Annunziata P, Giorgio A, De Santi L et al. Absence of CSF OCB is associated with delayed disability progression in relapsing-remitting MS-patients treated with interferon-beta. J Neurol Sci 2006; 244: 97-102.
29. Farrell MA, Kaufmann JC, Gilbert JJ et al. Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation. Neurology 1985; 35: 212-218. (Pubitemid 15171520)
30. Rammohan KW. Cerebrospinal fluid in multiple sclerosis. Review: Management Updates 2009; 12: 246-53.
31. Alonso A and Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71: 129-135.
32. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277. (Pubitemid 351222732)
33. Lauer K. Ecological studies for multiple sclerosis. Neurology 1997; 49: S18-S26.